본문 바로가기

Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
EUROPEAN NEUROPSYCHOPHARMACOLOGY90 · pp.1 · 2025
피인용
Web of Science 6Scopus 13
FWCI (Scopus)
4.03
JCR IF
JCR 2024 6.7
ISSN
0924-977X

저자

  1. Solmi, Marco제1저자University of Ottawa, Department of Psychiatry, Ontario, Canada
  2. Thompson, TrevorCentre for Chronic Illness and Ageing, University of Greenwich, London, United Kingdom
  3. Cortese, SamueleUniversity of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom
  4. Estradé, AndrésEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
  5. Agorastos, AgorastosAristotle University of Thessaloniki, II. Dept. of Psychiatry, Division of Neurosciences, Medical School, Faculty of Health Sciences, Greece
  6. Radua, JoaquimEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
  7. Dragioti, ElenaLinköping University, Pain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping, Sweden
  8. Vancampfort, DavyKatholieke Universiteit Leuven (KU Leuven), Department of Rehabilitation Sciences, Leuven, Belgium
  9. Thygesen, Lau CasparNational Institute of Public Health, University of Southern Denmark, Denmark
  10. Aschauer, HaraldBioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria
  11. Schlögelhofer, MonikaBioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria
  12. Aschauer, ElenaBioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria
  13. Schneeberger, AndresUniversity of California San Diego, California, United States
  14. Huber, Christian G.University of Basel, Universitäre Psychiatrische Kliniken Basel (UPK), Basel, Switzerland
  15. Hasler, GregorUniversity of Fribourg, Fribourg Network of Mental Health (RFSM), Fribourg, Switzerland
  16. Conus, PhilippeUniversity of Lausanne, Department of Psychiatry, Lausanne, Switzerland
  17. Cuénod, Kim Q. DoUniversity of Lausanne, Department of Psychiatry, Lausanne, Switzerland
  18. von Känel, RolandUniversity of Zurich, University Hospital Zurich, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, Switzerland
  19. Arrondo, GonzaloKarolinska Institutet, Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Stockholm, Sweden
  20. Fusar-Poli, PaoloEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
  21. Gorwood, PhilipUniversité Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France
  22. Llorca, Pierre-MichelUniversité Clermont Auvergne, CHU Clermont-Ferrand, Service de Psychiatrie B, Clermont-Ferrand, France
  23. Krebs, Marie-OdileInstitute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014, Paris, France
  24. Scanferla, ElisabettaUniversité Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France
  25. Kishimoto, TaishiroKeio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan
  26. Rabbani, GolamThe National Foundation of Mental Health of Bangladesh, Bangladesh
  27. Skonieczna-Żydecka, KarolinaPomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland
  28. Brambilla, PaoloUniversity of Milan, Department of Pathophysiology and Transplantation, Milan, Italy
  29. Favaro, AngelaUniversity of Padua, Neurosciences Department, Padua, Italy
  30. Takamiya, AkihiroKeio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan
  31. 이태영Pusan National University Yangsan Hospital, Department of Psychiatry, Yangsan, Republic of Korea
저자 214명 모두 보기

초록

There is no multi-country/multi-language study testing a-priori multivariable associations between non-modifiable/modifiable factors and validated wellbeing/multidimensional mental health outcomes before/during the COVID-19 pandemic. Moreover, studies during COVID-19 pandemic generally do not report on representative/weighted non-probability samples. The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) is a multi-country/multi-language survey conducting multivariable/LASSO-regularized regression models and network analyses to identify modifiable/non-modifiable factors associated with wellbeing (WHO-5)/composite psychopathology (P-score) change. It enrolled general population-representative/weighted-non-probability samples (26/04/2020-19/06/2022). Participants included 121,066 adults (age=42±15.9 years, females=64 %, representative sample=29 %) WHO-5/P-score worsened (SMD=0.53/SMD=0.74), especially initially during the pandemic. We identified 15 modifiable/nine non-modifiable risk and 13 modifiable/three non-modifiable protective factors for WHO-5, 16 modifiable/11 non-modifiable risk and 10 modifiable/six non-modifiable protective factors for P-score. The 12 shared risk/protective factors with highest centrality (network-analysis) were, for non-modifiable factors, country income, ethnicity, age, gender, education, mental disorder history, COVID-19-related restrictions, urbanicity, physical disorder history, household room numbers and green space, and socioeconomic status. For modifiable factors, we identified medications, learning, internet, pet-ownership, working and religion as coping strategies, plus pre-pandemic levels of stress, fear, TV, social media or reading time, and COVID-19 information. In multivariable models, for WHO-5, additional non-modifiable factors with |B|>1 were income loss, COVID-19 deaths. For modifiable factors we identified pre-pandemic levels of social functioning, hobbies, frustration and loneliness, and social interactions as coping strategy. For P-scores, additional non-modifiable/modifiable factors were income loss, pre-pandemic infection fear, and social interactions as coping strategy. COH-FIT identified vulnerable sub-populations and actionable individual/environmental factors to protect well-being/mental health during crisis times. Results inform public health policies, and clinical practice.

키워드

COH-FITCovid-19P-factorPsychiatrySurveyWell-being

식별자

Scopus EID
2-s2.0-85205003992
WoS UID
001381402000001